Bnp Paribas Edwards Lifesciences Corp Transaction History
Bnp Paribas
- $1.99 Trillion
- Q2 2024
A detailed history of Bnp Paribas transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bnp Paribas holds 227 shares of EW stock, worth $14,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227Holding current value
$14,945% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EW
# of Institutions
1,340Shares Held
467MCall Options Held
2.56MPut Options Held
2.56M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.53 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.36 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.71 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.34 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.11 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $40.7B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...